Primary buyer interest
Calm focus and stress
Selank is commonly researched for anxiety-related symptoms without a stimulant-style positioning.
COA VerifiedCognitive Peptides
$65.00
Purchase option
Buy more, save more
Not in stock yet. Leave your email and we will tell you when it is available.
Get notified when it's availableSelank is a synthetic heptapeptide analogue of tuftsin studied in GABA-A activity, BDNF expression, HPA stress-response, nootropic, anxiolytic, and immunomodulatory research. For research purposes only.
Orders ship from within Canada in discreet packaging. Express delivery is typically 1–3 business days after dispatch.
Standard returns are not accepted because research materials cannot be safely restocked after delivery. Contact support promptly about damaged, incorrect, or compromised items.
Reconstitution calculator
Enter three known values. The calculator converts the total vial amount and water added into a concentration, then shows the liquid volume and equivalent U-100 syringe units for the quantity entered.
The calculator does not choose a quantity. It converts the quantity you enter. One milligram equals 1,000 micrograms.
Bacteriostatic water is generally the most appropriate choice for multi-use research preparation because it contains a preservative for repeated vial access.
Selank buyer and evidence guide
Selank is usually compared by buyers who want a calm-focus or stress-resilience research peptide rather than a stimulant. It is a synthetic seven-amino-acid analogue of tuftsin, with studies involving anxiety symptoms, GABA-related binding, BDNF expression, learning, and stress response.
There is some human clinical literature, but it is small, mostly Russian-language, and much less independently replicated than evidence for established anxiety treatments. The honest buyer position is that Selank has an interesting anxiolytic signal, while effectiveness, ideal use, and long-term safety remain uncertain.
Primary buyer interest
Selank is commonly researched for anxiety-related symptoms without a stimulant-style positioning.
Human evidence
Two small Russian studies reported anxiety-related improvements versus benzodiazepine comparators.
Mechanistic interest
Preclinical work examines GABA-related binding, neurotrophins, memory, and stress pathways.
Evidence reality
The clinical evidence base is small and does not establish long-term effectiveness or safety.
The evidence includes small human studies and a broader preclinical mechanism literature.
| Evidence | Population or model | What was reported | Buyer takeaway |
|---|---|---|---|
| Small comparative anxiety study | 60 patients with anxiety-related disorders | Anxiolytic and mild nootropic effects versus Phenazepam | Human signal, but small and not broadly replicated |
| Small GAD and neurasthenia study | 62 patients | Anxiety outcomes reported as similar to Medazepam | Limited clinical evidence with reporting constraints |
| Animal and receptor research | GABA binding, BDNF, memory, and stress models | Mechanistic and behavioral changes | Supports hypotheses, not predictable human outcomes |
The clinical literature is not large enough to establish a dependable response rate, long-term safety profile, or equivalence to approved anxiety treatments.
Selank extends the tuftsin tetrapeptide sequence with Pro-Gly-Pro. Unlike stimulant-oriented compounds, it is discussed as an anxiolytic or stress-modulating peptide, with the buyer goal usually described as feeling calmer while preserving attention and mental clarity.
That description is more specific than the evidence can fully support. Small clinical studies reported anxiety-related benefits and mild nootropic effects, while animal and receptor studies provide possible GABA and neurotrophin mechanisms. Large modern placebo-controlled programs have not established how consistent those effects are.
A 60-person comparative study in people with phobic-anxiety or somatoform disorders reported anxiety improvement and mild nootropic effects, and a 62-person study in generalized anxiety or neurasthenia reported outcomes similar to a benzodiazepine comparator. Both were small, and the available abstracts do not provide the level of methodological detail expected from large international trials.
Animal work reports changes in BDNF, memory tasks, GABA-related binding, and stress behavior. These findings help explain the calm-focus concept but cannot establish a predictable personal effect, a replacement for mental-health care, or safety with antidepressants, sedatives, alcohol, or other psychoactive substances.
Selank is commonly confused with generic nootropic or stimulant goals.
| Buyer goal | How well Selank fits | Evidence note | Better next question |
|---|---|---|---|
| Calm focus or stress research | Closest fit | Small human signal plus preclinical mechanisms | How strong and reproducible is the effect? |
| Immediate stimulation | Poor fit | Not established as a stimulant | Is stimulation actually the desired outcome? |
| Treatment of an anxiety disorder | Not an evidence-based substitute | No large modern approval program | What diagnosis and established options apply? |
A buyer-focused page should clarify fit without turning preliminary research into a treatment claim.
Selank is the better conceptual fit when the buyer's main question is stress, anxiousness, or calm attention rather than raw stimulation. People expecting an immediate stimulant surge, appetite suppression, or a proven productivity effect are looking for an outcome the evidence does not establish.
The page should also not turn temporary stress into a self-diagnosed anxiety disorder. Persistent anxiety, panic, sleep disruption, depression, or impaired daily function deserves assessment from a qualified clinician because peptide research cannot identify or treat the underlying cause.
The 10mg label is the total nominal amount of lyophilized Selank in the vial. It does not describe a ready-to-use concentration, a recommended amount, or how long the vial will last.
Bison lists one Selank size, so the buying decision is mainly whether the compound's calm-focus research matches the intended question. Buyers should value defined sequence, batch identity, and COA clarity over unsupported promises about mood or productivity.
The listing identifies independent testing and COA availability. Before ordering, confirm that the available certificate identifies the compound or blend, batch or lot, test date, analytical method, and reported result. After delivery, compare the vial label with that exact documentation rather than relying on a generic certificate.
Identity, purity, fill quantity, sterility, and endotoxin testing answer different questions. A large purity percentage does not prove every other quality attribute, so buyers should check which tests are actually reported and avoid assuming that an unlisted result was performed.
The Bison Peptides Selank vial is supplied as a technical laboratory research material, not an authorized prescription formulation. The page summarizes published research to help buyers understand the compound, evidence, and product format; it is not an individual treatment or dosing recommendation.
Content reviewed August 11, 2026 by the Bison Peptides editorial team.
“This was my first Selank order and I wasn't sure what to expect from the site, but everything went smoothly. The 10mg vial arrived safely and the packaging was clean and professional. The product page was also straightforward without making the ordering process confusing.”
10mg ·
Connor L. · Verified buyer
“Really happy with the service on this order. Confirmation came through right away and the Selank arrived properly packaged with no damage. Everything was clearly labeled and matched the description on the website. I would feel comfortable purchasing here again.”
10mg ·
Alex G. · Verified buyer
“I specifically wanted Selank from a Canadian supplier and found this while comparing a few different stores. The site looked much cleaner than most and ordering was straightforward. My vial arrived sealed and well protected. Very good first experience with the company.”
10mg ·
Patrick D. · Verified buyer
Selank is commonly researched for anxiety-related behavior, stress response, calm attention, learning, GABA-related binding, and BDNF expression. It is usually positioned around calm focus rather than stimulation.
Yes, but they are small and mostly Russian-language. Two studies involving roughly 60 participants each reported anxiety-related benefits versus benzodiazepine comparators. The findings have not been supported by a large modern international trial program.
It is not generally described as a stimulant. Its research positioning is anxiolytic and stress-modulating, with some studies reporting mild nootropic effects. Buyers should not expect a proven immediate energy or productivity effect.
Small studies reported anxiolytic signals, but the evidence is not strong enough to establish predictable effectiveness or replace an approved anxiety treatment. Persistent or severe symptoms require professional assessment.
It means the vial lists 10mg of total lyophilized Selank. It does not define a prepared concentration, a personal amount, or a duration of use.
Selank is generally discussed for calm focus, stress, and anxiety-related research. Semax is more often discussed for cognitive, neuroprotective, and attention-related research. The Bison catalog currently lists Selank, not Semax.
Look for the Selank identity or sequence, batch or lot, test date, analytical method, and reported purity or identity result. A purity percentage does not by itself establish sterility, endotoxin control, or long-term stability.